1
TITLE: Should the SELECT Trial Make Us Comfortable Using GLP-1 Receptor Agonists in HFrEF?  Full Text
AUTHORS: Neves, Joao Sergio; Zannad, Faiez; Butler, Javed; Packer, Milton; Ferreira, Joao Pedro;
PUBLISHED: 2024, SOURCE: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, VOLUME: 84, ISSUE: 12
INDEXED IN: Scopus WOS
2
TITLE: Cardiovascular outcomes with exenatide in type 2 diabetes according to ejection fraction: The EXSCEL trial  Full Text
AUTHORS: Neves, Joao Sergio ; Leite, Ana Rita; Mentz, Robert J.; Holman, Rury R.; Zannad, Faiez; Butler, Javed; Packer, Milton; Ferreira, Joao Pedro;
PUBLISHED: 2024, SOURCE: EUROPEAN JOURNAL OF HEART FAILURE
INDEXED IN: Scopus WOS CrossRef
3
TITLE: Clinical Correlates and Prognostic Impact of Cognitive Dysfunction in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF
AUTHORS: Shen, Li; Dewan, Pooja; Ferreira, Joao Pedro; Cunningham, Jonathan W.; Jhund, Pardeep S.; Anand, Inder S.; Chandra, Alvin; Chiang, Lu May; Claggett, Brian; Desai, Akshay S.; Gong, Jianjian; Lam, Carolyn S. P.; Lefkowitz, Martin P.; Maggioni, Aldo P.; Martinez, Felipe; Packer, Milton; Redfield, Margaret M.; Rouleau, Jean L.; van Veldhuisen, Dirk J.; Zannad, Faiez; Zile, Michael R.; Solomon, Scott D.; Mcmurray, John J. V.; ...More
PUBLISHED: 2024, SOURCE: CIRCULATION, VOLUME: 150, ISSUE: 24
INDEXED IN: Scopus WOS
6
TITLE: Impact of anaemia and the effect of empagliflozin in heart failure with reduced ejection fraction: findings from EMPEROR-Reduced
AUTHORS: Ferreira, JP ; Anker, SD; Butler, J; Filippatos, G; Iwata, T; Salsali, A; Zeller, C; Pocock, SJ; Zannad, F; Packer, M;
PUBLISHED: 2022, SOURCE: EUROPEAN JOURNAL OF HEART FAILURE, VOLUME: 24, ISSUE: 4
INDEXED IN: Scopus WOS CrossRef: 40
7
TITLE: Reconsidering the ejection fraction centric view of pharmacologic treatment for heart failure
AUTHORS: Ferreira, JP ; Packer, M; Butler, J; Zannad, F;
PUBLISHED: 2022, SOURCE: EUROPEAN JOURNAL OF HEART FAILURE
INDEXED IN: WOS CrossRef: 12
8
TITLE: Mineralocorticoid Receptor Antagonists and Empagliflozin in Patients With Heart Failure and Preserved Ejection Fraction  Full Text
AUTHORS: Ferreira, Joao Pedro ; Butler, Javed; Zannad, Faiez; Filippatos, Gerasimos; Schueler, Elke; Steubl, Dominik; Zeller, Cordula; Januzzi, James L.; Pocock, Stuart; Packer, Milton; Anker, Stefan D.;
PUBLISHED: 2022, SOURCE: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, VOLUME: 79, ISSUE: 12
INDEXED IN: Scopus WOS CrossRef: 40
9
TITLE: Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial
AUTHORS: Butler, Javed; Filippatos, Gerasimos; Siddiqi, Tariq Jamal; Brueckmann, Martina; Bohm, Michael; Chopra, Vijay K.; Ferreira, Joao Pedro ; Januzzi, James L.; Kaul, Sanjay; Pina, Ileana L.; Ponikowski, Piotr; Shah, Sanjiv J.; Senni, Michele; Vedin, Ola; Verma, Subodh; Peil, Barbara; Pocock, Stuart J.; Zannad, Faiez; Packer, Milton; Anker, Stefan D.;
PUBLISHED: 2022, SOURCE: CIRCULATION, VOLUME: 145, ISSUE: 3
INDEXED IN: WOS CrossRef: 122
10
TITLE: Outcomes with empagliflozin in heart failure with preserved ejection fraction using DELIVER-like endpoint definitions
AUTHORS: Anker, Stefan D.; Siddiqi, Tariq Jamal; Filippatos, Gerasimos; Zannad, Faiez; Ferreira, Joao Pedro ; Pocock, Stuart J.; Brueckmann, Martina; Zeller, Cordula; Packer, Milton; Butler, Javed;
PUBLISHED: 2022, SOURCE: EUROPEAN JOURNAL OF HEART FAILURE, VOLUME: 24, ISSUE: 8
INDEXED IN: Scopus WOS CrossRef: 13
Page 1 of 3. Total results: 24.